In contrast, Inamura et al. reported that elevated B7-H3 expression corresponded to lower disease-free survival (DFS), particularly in the earlier stages of the disease, suggesting that the molecule may serve as a useful biomarker in early-stage pancreatic cancer [136]. This evidence concerns the gene CD276 and pancreatic neoplasm.